Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Allurion Technologies, Inc. Common Stock (NY: ALUR )

8.690 +4.990 (+134.86%)
Official Closing Price Updated: 7:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Allurion Technologies, Inc. Common Stock

< Previous 1 2 Next >
Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces Preliminary First Quarter 2024 Results
From Allurion Technologies, Inc.
Via Business Wire
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
From Allurion Technologies, Inc.
Via Business Wire
Allurion Expands Virtual Care Suite to the United States
From Allurion Technologies, Inc.
Via Business Wire
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
From Allurion Technologies, Inc.
Via Business Wire
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
From Allurion Technologies, Inc.
Via Business Wire
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
From Allurion Technologies, Inc.
Via Business Wire
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
From Allurion Technologies, Inc.
Via Business Wire
Allurion to Participate in Cowen’s 44th Annual Health Care Conference
From Allurion Technologies, Inc.
Via Business Wire
Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
From Allurion Technologies, Inc.
Via Business Wire
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
From Allurion Technologies, Inc.
Via Business Wire
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
From Allurion Technologies, Inc.
Via Business Wire
New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program
From Allurion Technologies, Inc.
Via Business Wire
Allurion’s Digital Platform Gains Traction with Expanded Strategic Partnership
From Allurion Technologies, Inc.
Via Business Wire
Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
Allurion to Participate in the Jefferies London Healthcare Conference
From Allurion Technologies, Inc.
Via Business Wire
Allurion to Report Third Quarter 2023 Financial Results on November 13, 2023
From Allurion Technologies, Inc.
Via Business Wire
Allurion Completes Enrollment in Pivotal AUDACITY Trial for the Allurion Balloon
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces Acceptance of Five Abstracts for Presentation at Obesity Week 2023
From Allurion Technologies, Inc.
Via Business Wire
Allurion Featured at the 2023 International Bariatric Club Oxford University World Congress
From Allurion Technologies, Inc.
Via Business Wire
Allurion Introduces Coach Iris: A 24/7 Generative AI-Powered Weight Loss Coach
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces Acceptance of Nine Scientific Presentations at IFSO 2023 World Congress
From Allurion
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.